Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Liabilities and Shareholders Equity (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Liabilities and Shareholders Equity data on record, last reported at $122.0 million in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity fell 5.95% year-over-year to $122.0 million; the TTM value through Sep 2025 reached $487.8 million, down 8.06%, while the annual FY2024 figure was $122.5 million, 9.54% down from the prior year.
  • Liabilities and Shareholders Equity reached $122.0 million in Q3 2025 per UTMD's latest filing, up from $120.8 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $135.5 million in Q4 2023 and bottomed at $114.4 million in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $123.8 million, with a median of $122.5 million recorded in 2025.
  • Peak YoY movement for Liabilities and Shareholders Equity: increased 12.8% in 2021, then dropped 9.54% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $115.6 million in 2021, then grew by 7.12% to $123.9 million in 2022, then rose by 9.35% to $135.5 million in 2023, then decreased by 9.54% to $122.5 million in 2024, then fell by 0.46% to $122.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $122.0 million in Q3 2025, $120.8 million in Q2 2025, and $122.5 million in Q1 2025.